Description
While the study demonstrates that NPTX2 overexpression exhibits neurotoxicity and that correcting its misregulation rescues TDP-43-induced neurodegeneration, the specific mechanisms by which NPTX2 causes neuronal death remain unexplained. This mechanistic gap limits therapeutic targeting of this pathway.
Gap type: unexplained_observation Source paper: A model of human neural networks reveals NPTX2 pathology in ALS and FTLD. (2024, Nature, PMID:38355792)
Resolution criteria
[“NPTX2 overexpression in primary cortical neurons causes >=30% reduction in synaptic density (synaptophysin puncta) and >=40% increase in Caspase-3+ cells at 14 days”, “Co-immunoprecipitation identifies NPTX2 binding partners (AMPA receptor subunits, PSD-95) in overexpression context”, “CRISPR knockdown of NPTX2 in vivo (AAV-shNPTX2) in wild-type mice confirms normal synaptic function is NPTX2-dependent”, “NPTX2 receptor identification via affinity purification mass spectrometry reveals mechanism of excitotoxic signaling”]
Evidence summary
{“resolution_pipeline”: “scidex.atlas.gap_closure_pipeline”, “task_id”: “f4f7b129-0f43-4c84-abd8-20d4e701842d”, “evaluated_at”: “2026-04-28T19:10:17.221662+00:00”, “resolution_summary”: “Resolved by hypothesis h-3c73c503dd: Aβ42 oligomers drive TDP-43 phosphorylation at s409/410 through CDK5/p25 activation specifically in AD, generating a phospho-signature distinct from ALS/FTLD. Supporting evidence includes debate sess_SDA-2026-04-14-gap-pubmed-20260410-181356-57d1f917.”, “match_counts”: {“hypothesis_matches”: 5, “debate_matches”: 5, “paper_matches”: 0}, “hypothesis_matches”: [{“id”: “h-3c73c503dd”, “title”: “Aβ42 oligomers drive TDP-43 phosphorylation at s409/410 through CDK5/p25 activation specifically in AD, generating a phospho-signature distinct from ALS/FTLD”, “score”: 0.339, “reason”: “15 token overlaps; entity overlap: als, ftld”, “analysis_id”: “SDA-2026-04-07-gap-pubmed-20260406-062202-094b44bf”, “target_gene”: “CDK5R1 (p25 regulatory subunit)”, “target_pathway”: null, “disease”: “neurodegeneration”, “composite_score”: 0.595, “confidence_score”: 0.62, “status”: “proposed”, “pubmed_evidence_ids”: [“15728260”, “28794024”, “34930382”]}, {“id”: “h-alsmnd-01446b71d93f”, “title”: “MATR3 Nuclear Body Disruption Impairs RNA Processing Hubs and Triggers Splicing Defects in ALS Motor Neurons”, “score”: 0.248, “reason”: “9 token overlaps; entity overlap: als”, “analysis_id”: null, “target_gene”: “MATR3,U1 snRNP,SNRPB,SNRNP70, splicing machinery,spliceosome”, “target_pathway”: null, “disease”: “ALS”, “composite_score”: 0.801172, “confidence_score”: 0.75, “status”: “open”, “pubmed_evidence_ids”: [“20301623”, “24686783”, “30157547”, “35205163”, “38891112”]}, {“id”: “h-alsmnd-e448328ae294”, “title”: “GLE1-Mediated mRNA Export Defect Creates Translation-Competent mRNA Starvation in ALS Motor Neuron Axons”, “score”: 0.246, “reason”: “9 token overlaps; entity overlap: als”, “analysis_id”: null, “target_gene”: “GLE1,DBP10,EXPORTIN-1,XPO1,mRNA export machinery,NPC”, “target_pathway”: null, “disease”: “ALS”, “composite_score”: 0.822847, “confidence_score”: 0.75, “status”: “open”, “pubmed_evidence_ids”: [“25343993”, “26776475”, “26921650”, “34025336”]}, {“id”: “h-72c719461c”, “title”: “C9orf72 ASO Treatment Reverses TDP-43 Pathology in ALS/FTD”, “score”: 0.238, “reason”: “5 token overlaps; entity overlap: als”, “analysis_id”: “test-hypothesis-fixtures-v1”, “target_gene”: “C9orf72”, “target_pathway”: null, “disease”: “neurodegeneration”, “composite_score”: 0.72, “confidence_score”: 0.88, “status”: “proposed”, “pubmed_evidence_ids”: [“21944792”, “28960178”, “29460270”, “39605053”, “40520109”]}, {“id”: “h-alsmnd-c5d2e9c2edeb”, “title”: “SFPQ Paralog Displacement Triggers Cryptic Polyadenylation and Global RNA Stability Loss in ALS Motor Neurons”, “score”: 0.237, “reason”: “8 token overlaps; entity overlap: als”, “analysis_id”: null, “target_gene”: “SFPQ,NONO,PSP1,TARDBP,poly(A) machinery,CPSF,PABPN1”, “target_pathway”: null, “disease”: “ALS”, “composite_score”: 0.864139, “confidence_score”: 0.75, “status”: “open”, “pubmed_evidence_ids”: [“36414621”, “40369342”, “41120750”, “41836882”]}], “debate_matches”: [{“id”: “sess_SDA-2026-04-14-gap-pubmed-20260410-181356-57d1f917”, “title”: “The study shows dramatic functional recovery and muscle re-innervation after cytoplasmic TDP-43 clearance, even following motor neuron death. The cellular and molecular mechanisms underlying this unexpected regenerative capacity in neurodegenerative disease are not explained.\n\nGap type: unexplained_observation\nSource paper: Functional recovery in new mouse models of ALS/FTLD after clearance of pathological cytoplasmic TDP-43. (2015, Acta neuropathologica, PMID:26197969)”, “score”: 0.641, “reason”: “10 token overlaps; entity overlap: als, ftld, pmid”, “analysis_id”: “SDA-2026-04-14-gap-pubmed-20260410-181356-57d1f917”, “quality_score”: 0.85, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-07-gap-pubmed-20260406-062202-094b44bf_task_9aae8fc5”, “title”: “TDP-43 inclusions occur in AD, ALS, and FTLD but the pathogenic mechanisms leading to TDP-43 pathology may differ between diseases. Understanding disease-specific drivers could reveal why TDP-43 shows limbic distribution in AD versus other patterns in ALS/FTLD.\n\nGap type: unexplained_observation\nSource paper: TDP-43 Pathology in Alzheimer’s Disease. (2021, Mol Neurodegener, PMID:34930382)”, “score”: 0.605, “reason”: “8 token overlaps; entity overlap: als, ftld, pmid”, “analysis_id”: “SDA-2026-04-07-gap-pubmed-20260406-062202-094b44bf”, “quality_score”: 0.697, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-07-gap-pubmed-20260406-062141-fc60e018_task_73907230”, “title”: “The study identifies cGAS/STING activation as a consequence of TDP-43-mediated mtDNA release, but the temporal dynamics and whether this pathway drives chronic inflammation or acute toxicity remains unclear. This distinction is critical for determining therapeutic timing and approach.\n\nGap type: unexplained_observation\nSource paper: TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS. (2020, Cell, PMID:33031745)”, “score”: 0.593, “reason”: “9 token overlaps; entity overlap: als, pmid, tdp-43-”, “analysis_id”: “SDA-2026-04-07-gap-pubmed-20260406-062141-fc60e018”, “quality_score”: 0.73, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-07-gap-pubmed-20260406-062212-ca78691c_task_9aae8fc5”, “title”: “The abstract identifies that neurons show resistance to autophagy induction, but the mechanistic basis remains incompletely defined. Understanding this resistance is crucial for developing neuron-targeted autophagy therapies for ALS.\n\nGap type: unexplained_observation\nSource paper: Autophagy and ALS: mechanistic insights and therapeutic implications. (2022, Autophagy, PMID:34057020)”, “score”: 0.547, “reason”: “10 token overlaps; entity overlap: als, pmid”, “analysis_id”: “SDA-2026-04-07-gap-pubmed-20260406-062212-ca78691c”, “quality_score”: 0.65, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-08-gap-pubmed-20260406-062212-6777e5dd_task_9aae8fc5”, “title”: “While ALS-causing mutations impair autophagy factors, the neuron-specific effects remain incompletely defined according to the authors. This knowledge gap prevents precise understanding of selective neuronal vulnerability in ALS.\n\nGap type: open_question\nSource paper: Autophagy and ALS: mechanistic insights and therapeutic implications. (2022, Autophagy, PMID:34057020)”, “score”: 0.536, “reason”: “10 token overlaps; entity overlap: als, pmid”, “analysis_id”: “SDA-2026-04-08-gap-pubmed-20260406-062212-6777e5dd”, “quality_score”: 0.812, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}], “paper_matches”: []}